1.
Ravasio R, Pisarra P, Porzio R, Comaschi M. Economic Evaluation of Canagliflozin versus Glimepiride and Sitagliptin in Dual Therapy with Metformin for the Treatment of Type 2 Diabetes in Italy. Grhta [Internet]. 2016 Jul. 18 [cited 2024 Nov. 21];3(2):92-101. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/414